llyon
nvoon
abbvon
mrkon
Portfolio Glider

The Healthcare Trade

A new class of blockbuster drugs is reshaping healthcare and creating some of the most valuable companies in medicine. This portfolio anchors on the leaders behind that breakthrough and broadens into large pharmaceutical makers, medical device companies, and biotech.

Investisseurs
94
Jours de trading
—
Rééquilibrage
Quotidien

Performance

ROI 1 j
-0.01%
ROI 7 j
-3.84%
ROI 30 j
+3.25%
TVL

$164.47K

APY max

—

Répartition

llyon

LLYon

$39,472.39

24%
nvoon

NVOon

$19,736.20

12%
abbvon

ABBVon

$18,091.51

11%
mrkon

MRKon

$14,802.15

9%
pfeon

PFEon

$13,157.46

8%
abton

ABTon

$13,157.46

8%
isrgon

ISRGon

$11,512.78

7%
regnon

REGNon

$11,512.78

7%
vrtxon

VRTXon

$11,512.78

7%
unhon

UNHon

$11,512.78

7%
The Healthcare Trade | Sumex